{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:24:46Z","timestamp":1795242286534,"version":"4.10.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,26]],"date-time":"2027-08-26T00:00:00Z","timestamp":1819238400000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107953","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:35:54Z","timestamp":1786084554000},"page":"107953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between tazobactam\u2013piperacillin exposure and the subsequent emergence in gram-negative rods: Findings from a single-institution cohort study"],"prefix":"10.1016","volume":"67","author":[{"given":"Ezaki","family":"Masayoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kato","family":"Noriko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-4554","authenticated-orcid":false,"given":"Nagaoka","family":"Kentaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murai","family":"Yushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugie","family":"Kazushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5367-406X","authenticated-orcid":false,"given":"Kamihara","family":"Yusuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8019-383X","authenticated-orcid":false,"given":"Hounoki","family":"Hiroyuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watanabe","family":"Toru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawagishi","family":"Toshiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-2095","authenticated-orcid":false,"given":"Yonemoto","family":"Naohiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-101X","authenticated-orcid":false,"given":"Kawasuji","family":"Hitoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niimi","family":"Hideki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-6411","authenticated-orcid":false,"given":"Morinaga","family":"Yoshitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-5029","authenticated-orcid":false,"given":"Ohama","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5325-4173","authenticated-orcid":false,"given":"Akeda","family":"Yukihiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2088-8724","authenticated-orcid":false,"given":"Yamamoto","family":"Yoshihiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107953_bib0001","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/jama.2016.11764","article-title":"Antimicrobial resistance","volume":"316","author":"Marston","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0002","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/cix612","article-title":"Predicting resistance to piperacillin-tazobactam, cefepime and meropenem in septic patients with bloodstream infection due to gram-negative bacteria","volume":"65","author":"Vazquez-Guillamet","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jcrc.2018.07.003","article-title":"Emergence of antimicrobial resistance to piperacillin\/tazobactam or meropenem in the ICU: intermittent versus continuous infusion. A retrospective cohort study","volume":"47","author":"Dhaese","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0004","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S2542-5196(20)30099-1","article-title":"Human faeces-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli discharge into sanitation systems in 2015 and 2030: a global and regional analysis","volume":"4","author":"Berendes","year":"2020","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2012.06.004","article-title":"Antibiotic therapy for inducible AmpC \u03b2-lactamase-producing gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?","volume":"40","author":"Harris","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0006","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12879-017-2502-x","article-title":"Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"17","author":"Seo","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkv346","article-title":"Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis","volume":"71","author":"Harris","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.105860","article-title":"Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems","volume":"55","author":"Tan","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01038-20","article-title":"Emergence of resistance in Klebsiella aerogenes to piperacillin-tazobactam and ceftriaxone","volume":"65","author":"Custodio","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106809","article-title":"Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC \u03b2-lactamase-producing enterobacterales: a multi-centre retrospective propensity-weighted study","volume":"62","author":"Maillard","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0012","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1038\/s41467-020-18668-2","article-title":"Piperacillin\/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B","volume":"11","author":"Hubbard","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0013","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jac\/dky453","article-title":"OXA-1 beta-lactamase and non-susceptibility to penicillin\/beta-lactamase inhibitor combinations among ESBL-producing Escherichia coli","volume":"74","author":"Livermore","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0014","article-title":"Piperacillin\/tazobactam-resistant, cephalosporin-susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types","volume":"8","author":"Edwards","year":"2022","journal-title":"Microb Genom"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0016","article-title":"Antibiotic duration for common bacterial infections-a systematic review","volume":"7","author":"Mo","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13613-017-0296-z","article-title":"Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration","volume":"7","author":"Yusuf","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13756-022-01146-3","article-title":"Use of broad-spectrum antimicrobials for more than 72 h and the detection of multidrug-resistant bacteria in Japanese intensive care units: a multicenter retrospective cohort study","volume":"11","author":"Yoshida","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/phar.2201","article-title":"Duration of exposure to antipseudomonal \u03b2-lactam antibiotics in the critically ill and development of new resistance","volume":"39","author":"Teshome","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0020","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/cid\/ciz668","article-title":"Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection: a multisite retrospective study","volume":"70","author":"Babich","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajic.2022.05.025","article-title":"Correlation between antibiotic use and antibiotic resistance: a multicenter study using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system in Hokkaido, Japan","volume":"51","author":"Kagami","year":"2023","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102474","article-title":"Evaluation of antimicrobial selective pressure using the multicenter semiautomatic surveillance system Japan surveillance for infection prevention and healthcare epidemiology","volume":"17","author":"Hayakawa","year":"2024","journal-title":"J Infect Public Health"},{"issue":"Supplement","key":"10.1016\/j.ijantimicag.2026.107953_bib0023","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jiac.2015.12.019","article-title":"JAID\/JSC guidelines for the treatment of respiratory infectious diseases: the JAID\/JSC guide to clinical management of infectious disease","volume":"22","author":"Mikasa","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0024","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10096-004-1111-y","article-title":"Risk factors for mortality in patients with anaerobic bacteremia","volume":"23","author":"Wilson","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0026","series-title":"CLSI supplement M100","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2020"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.107","article-title":"Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp","volume":"2","author":"Chen","year":"2023","journal-title":"Imeta"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0028","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0029","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1101\/gr.186072.114","article-title":"CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes","volume":"25","author":"Parks","year":"2015","journal-title":"Genome Res"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/JCM.06094-11","article-title":"Multilocus sequence typing of total-genome-sequenced bacteria","volume":"50","author":"Larsen","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0031","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12859-018-2336-6","article-title":"Rapid and precise alignment of raw reads against redundant databases with KMA","volume":"19","author":"Clausen","year":"2018","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0032","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"392","author":"Daneman","year":"2025","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0033","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jinf.2019.10.008","article-title":"The effect of antibiotics on the composition of the intestinal microbiota - a systematic review","volume":"79","author":"Zimmermann","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0034","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/cid\/ciw283","article-title":"Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis","volume":"63","author":"Karanika","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijantimicag.2026.107953_bib0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa","volume":"34","author":"Livermore","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.ijantimicag.2026.107953_bib0036","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC \u03b2-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:37:53Z","timestamp":1794267473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926002402"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107953","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between tazobactam\u2013piperacillin exposure and the subsequent emergence in gram-negative rods: Findings from a single-institution cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107953"}}